accountvital to his strategy for profitable growth. Novartis wants to keep R&D spending high, unlike competitors such as Pfizer Inc. which, in February, because of the loss of patent protection for its blockbuster cholesterol drug Lipitor, said it will slash...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Novartis Prunes Costs For Stronger Growth
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account